Reference
1. Ballerie A, Alix L, Bajeux E, Jégo P, Lescoat A, Hue B. The collaboration of clinical pharmacists and physicians for medication safety. Lancet, 2020; 394(10216):2240.
2. Hall W. ACP Journal Club. Review: pharmacist care improves therapeutic and safety outcomes in older adults. Ann. Intern. Med. 2013; 159(10):JC6.
3. Lundberg G. The clinical pharmacist. JAMA. 1983; 249(9):1193.
4. Fuster V. No Such Thing as Ideal Blood Pressure: A Case for Personalized Medicine. J. Am. Coll. Cardiol. 2016; 67(25):3014-15.
5. Tsuyuki R, Houle S, Charrois T, Kolber M, Rosenthal M, Lewanczuk R, et al. Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015; 132(2):93-100.
6. Gomez A. Availability of Pharmacist-Prescribed Contraception in California, 2017. JAMA. 2017; 318(22):2253-4.
7. Avery A, Pringle M. Extended prescribing by UK nurses and pharmacists. BMJ. 2005; 331(7526):1154-5.
8. Kouladjian O’Donnell L, Sawan M. Deprescribing needs to be considered in the pharmacists’ prescribing role. Med. J. Aust. 2020; 212(3):141-e141.
9. Abouk R, Pacula R, Powell D. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. JAMA Intern Med. 2019; 179(6):805-11.
10. Hill L, Reveles K, Evoy K. State-Level Approaches to Expanding Pharmacists’ Authority to Dispense Naloxone May Affect Accessibility. JAMA Intern Med. 2019; 179(10):1442-3.
11. Pearson G. Evolution in the practice of pharmacy–not a revolution! CMAJ. 2007; 176(9):1295-6.
12. Sayburn A. Pharmacists could work in GP premises under proposed new model of care. BMJ. 2015; 351:h4427.
13. Torjesen I. More than 400 pharmacists will be recruited to GP surgeries by next year. BMJ. 2015; 351:h6167.
14. Friend S. Delegation of flu jabs: pharmacists are trained and vigilant. BMJ. 2019; 367:l6884.
15. Tribble A, Lee B, Flett K, Handy L, Gerber J, Hersh A, et al. Appropriateness of Antibiotic Prescribing in U.S. Children’s Hospitals: A National Point Prevalence Survey. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. https://doi.org/10.1093/cid/ciaa036
16. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002; 359(9315):1373-8.
17. Classen D, Pestotnik S, Evans R, Burke J. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991; 266(20):2847-51.
18. Hawkey C, Hodgson S, Norman A, Daneshmend T, Garner S. Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ. 1990; 300(6730):986-990.
19. Steinman M, Landefeld C. Overcoming Inertia to Improve Medication Use and Deprescribing. JAMA. 2018; 320(18):1867-9.
20. Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J. Clin. Oncol. 2015; 33(13):1453-9.
21. Zermansky A, Petty D, Raynor D, Freemantle N, Vail A, Lowe C. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001; 323(7325):1340-3.
22. Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018; 320(18):1889-98.
23. Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann. Intern. Med. 2012; 157(1):1-10.
24. Tsuyuki R, Al Hamarneh Y, Jones C, Hemmelgarn B. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial. J. Am. Coll. Cardiol. 2016; 67(24):2846-2854.
25. Bland C, Jones B. Pharmacists Filling the Gap Within Penicillin Allergy Assessment and Skin Testing. Clin. Infect. Dis. 2020. https://doi.org/10.1093/cid/ciaa978
26. Leape L, Cullen D, Clapp M, Burdick E, Demonaco H, Erickson J, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282(3):267-270.
27. Green B, Cook A, Ralston J, Fishman P, Catz S, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008; 299(24):2857-67.
28. Siegel D. ACP Journal Club: in uncontrolled hypertension, a pharmacist-prescribing intervention reduced blood pressure at 6 months. Ann. Intern. Med. 2015; 163(10):JC7.
29. Dunn S, Birtcher K, Beavers C, Baker W, Brouse S, Page R, et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J. Am. Coll. Cardiol. 2015; 66(19):2129-2139.
30. Aluh D, Norberg M. Community pharmacists as a resource in task-shifted interventions for depression. Lancet Psychiatry. 2020; 7(5):e24.
31. Radley A, de Bruin M, Inglis S, Donnan P, Hapca A, Barclay S, et al. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial. The lancet Gastroenterology & hepatology. 2020.
32. Franklin B, Abel G, Shojania K. Medication non-adherence: an overlooked target for quality improvement interventions. BMJ Qual Saf. 2020; 29(4):271-3.
33. Mes M, Katzer C, Chan A, Wileman V, Taylor S, Horne R. Pharmacists and medication adherence in asthma: a systematic review and meta-analysis. Eur. Respir. J. 2018; 52(2): 1800485.
34. Sivaraman V, Wise K, Cotton W, Barbar-Smiley F, AlAhmed O, MacDonald D, et al. Previsit Planning Improves Pneumococcal Vaccination Rates in Childhood-Onset SLE. Pediatrics 2020; 145(1).
35. McKenney J, Slining J, Henderson H, Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973; 48(5):1104-11.
36. Schulz M, Griese-Mammen N, Anker S, Koehler F, Ihle P, Ruckes C, et al. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur. J. Heart Fail. 2019; 21(8):1012-21.
37. Lowrie R, Mair F, Greenlaw N, Forsyth P, Jhund P, McConnachie A, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur. Heart J. 2012; 33(3):314-24.
38. Straus S, Dolovich L. In hospitalized adults with polypharmacy, a multifaceted pharmacist intervention reduced readmissions at 180 days. Ann. Intern. Med. 2018; 168(10):JC59.
39. Lapointe-Shaw L, Bell C, Austin P, Abrahamyan L, Ivers N, Li P, et al. Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study. BMJ Qual Saf. 2020; 29(1):41-51.
40. Morgan S, Bathula H, Moon S. Pricing of pharmaceuticals is becoming a major challenge for health systems. BMJ. 2020; 368:l4627.
41. Caplan A. Obtaining prescription drugs in America: it’s no bargain. J. Clin. Invest. 2019; 129(11):4558-9.
42. Buckley M, Knutson K, Agarwal S, Lansburg J, Wicks L, Saggar R, et al. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill. Ann Pharmacother. 2020; 54(2):105-112.
43. Muñoz-Pichuante D, Villa-Zapata L. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study. Journal of clinical pharmacy and therapeutics 2020. https://doi.org/10.1111/jcpt.13195
44. Hyland S, Kramer B, Fada R, Lucki M. Clinical Pharmacist Service Associated With Improved Outcomes and Cost Savings in Total Joint Arthroplasty. The Journal of arthroplasty 2020. https://doi.org/10.1016/j.arth.2020.04.022
45. Abdulrhim S, Sankaralingam S, Ibrahim M, Awaisu A. The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews. Primary care diabetes 2020. https://doi.org/10.1016/j.pcd.2019.12.007
46. Rimmer A. Shortened medical training for physiotherapists and pharmacists must not reduce standards, doctors warn. BMJ. 2020; 368:m551.
47. Boulanger Renaud F.(2011). Transforming health professionals’ education. Lancet, 377(9773), 1237; author reply 1238-9. doi:10.1016/S0140-6736(11)60497-2.
48. McCrary M, Goldstein J. Pharmacist-Led Education to Discontinue Inappropriate Prescribing. JAMA. 2019; 321(13):1313-4.
49. Johnson K, Khakban A, Bryan S, Sin D, Sadatsafavi M. Healthcare system encounters before COPD diagnosis: a registry-based longitudinal cohort study. Thorax. 2020; 75(2):108-15.